---
figid: PMC9563811__cancers-14-04875-g001
pmcid: PMC9563811
image_filename: cancers-14-04875-g001.jpg
figure_link: /pmc/articles/PMC9563811/figure/cancers-14-04875-f001/
number: Figure 1
figure_title: ''
caption: Flow chart of the HMGB1-related study design and analysis. (1) Differential
  expression of HMGB1 in all cancer types. (2) Clinicopathological and survival. (3)
  Somatic mutation analysis. (4) Interacted-genes and pathway enrichment analysis.
  (5) Validate in vitro. (6) ICPs and immunotherapy analysis. * Statistically significant
  p-value calculated (Pearson correlation analysis) p < 0.05, ** p < 0.01, *** p <
  0.001.
article_title: Oncogenic Role of HMGB1 as An Alarming in Robust Prediction of Immunotherapy
  Response in Colorectal Cancer.
citation: Huijiao Lu, et al. Cancers (Basel). 2022 Oct;14(19):4875.
year: '2022'

doi: 10.3390/cancers14194875
journal_title: Cancers
journal_nlm_ta: Cancers (Basel)
publisher_name: MDPI

keywords:
- HMGB1
- clinical prognosis
- antitumor immune responses
- cancer-associated fibroblasts (CAFs)
- tumor immune microenvironment (TME)
- immune checkpoints molecules (ICPs)
- methylated DNA
- phosphorylated protein
- colorectal cancer

---
